You are viewing a single comment's thread from:
RE: Alkermes (ALKS): Is the Correction Complete?
Alkermes to Present at Goldman Sachs 39th Annual Global Healthcare Conference
Alkermes Receives $50 Million Payment From Biogen Following Review of Preliminary Gastrointestinal Tolerability Data From the Ongoing BIIB098 Clinical Development Program
@haejin what do you think?
The Ascended bullish triangle scenario could play out! I'd give the corrective a 55% and the triangle a 45% ratio.